Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.

MLA

Decloedt, Eric H., et al. “Benefit v. Risk When Using Chloroquine in Patients with Severe COVID-19 Disease.” SAMJ: South African Medical Journal, vol. 110, no. 5, May 2020, pp. 8–10. EBSCOhost, https://doi.org/10.7196/samj.2020.v110i5.14761.

APA

Decloedt, E. H., Reuter, H., Allwood, B., Parker, A., Koegelenberg, C. F. N., Blockman, M., & Taljaard, J. (2020). Benefit v. risk when using chloroquine in patients with severe COVID-19 disease. SAMJ: South African Medical Journal, 110(5), 8–10. https://doi.org/10.7196/samj.2020.v110i5.14761

Chicago

Decloedt, Eric H., Helmuth Reuter, Brian Allwood, Arifa Parker, Coenraad F. N. Koegelenberg, Marc Blockman, and Jantjie Taljaard. 2020. “Benefit v. Risk When Using Chloroquine in Patients with Severe COVID-19 Disease.” SAMJ: South African Medical Journal 110 (5): 8–10. doi:10.7196/samj.2020.v110i5.14761.